Rimm D - Search Results

1

Comparative prognostic value of epidermal growth factor quantitative protein expression compared with FISH for head and neck squamous cell carcinoma.

Pectasides E, Rampias T, Kountourakis P, Sasaki C, Kowalski D, Fountzilas G, Zaramboukas T, Rimm D, Burtness B, Psyrri A. Pectasides E, et al. Among authors: rimm d. Clin Cancer Res. 2011 May 1;17(9):2947-54. doi: 10.1158/1078-0432.CCR-10-2040. Epub 2011 Feb 25. Clin Cancer Res. 2011. PMID: 21355076

2

Expression of c-met is a strong independent prognostic factor in breast carcinoma.

Ghoussoub RA, Dillon DA, D'Aquila T, Rimm EB, Fearon ER, Rimm DL. Ghoussoub RA, et al. Among authors: rimm eb, rimm dl, d aquila t. Cancer. 1998 Apr 15;82(8):1513-20. doi: 10.1002/(sici)1097-0142(19980415)82:8<1513::aid-cncr13>3.0.co;2-7. Cancer. 1998. PMID: 9554529

3

Loss of p120ctn in human colorectal cancer predicts metastasis and poor survival.

Gold JS, Reynolds AB, Rimm DL. Gold JS, et al. Among authors: rimm dl. Cancer Lett. 1998 Oct 23;132(1-2):193-201. doi: 10.1016/s0304-3835(98)00190-6. Cancer Lett. 1998. PMID: 10397474 Free article.

4

Met expression is associated with poor outcome in patients with axillary lymph node negative breast carcinoma.

Camp RL, Rimm EB, Rimm DL. Camp RL, et al. Among authors: rimm eb, rimm dl. Cancer. 1999 Dec 1;86(11):2259-65. doi: 10.1002/(sici)1097-0142(19991201)86:11<2259::aid-cncr13>3.0.co;2-2. Cancer. 1999. PMID: 10590366

5

A high number of tumor free axillary lymph nodes from patients with lymph node negative breast carcinoma is associated with poor outcome.

Camp RL, Rimm EB, Rimm DL. Camp RL, et al. Among authors: rimm eb, rimm dl. Cancer. 2000 Jan 1;88(1):108-13. Cancer. 2000. PMID: 10618612

6

Novel inactivating mutations of transforming growth factor-beta type I receptor gene in head-and-neck cancer metastases.

Chen T, Yan W, Wells RG, Rimm DL, McNiff J, Leffell D, Reiss M. Chen T, et al. Among authors: rimm dl. Int J Cancer. 2001 Sep 1;93(5):653-61. doi: 10.1002/ijc.1381. Int J Cancer. 2001. PMID: 11477574

7

Tissue microarray analysis of beta-catenin in colorectal cancer shows nuclear phospho-beta-catenin is associated with a better prognosis.

Chung GG, Provost E, Kielhorn EP, Charette LA, Smith BL, Rimm DL. Chung GG, et al. Among authors: rimm dl. Clin Cancer Res. 2001 Dec;7(12):4013-20. Clin Cancer Res. 2001. PMID: 11751495

8

Quantitative examination of mechanophysical tumor cell enrichment in fine-needle aspiration specimens.

Ernst LM, Rimm DL. Ernst LM, et al. Cancer. 2002 Oct 25;96(5):275-9. doi: 10.1002/cncr.10746. Cancer. 2002. PMID: 12378594 Free article.

9

Tissue microarray-based analysis shows phospho-beta-catenin expression in malignant melanoma is associated with poor outcome.

Kielhorn E, Provost E, Olsen D, D'Aquila TG, Smith BL, Camp RL, Rimm DL. Kielhorn E, et al. Among authors: rimm dl, d aquila tg. Int J Cancer. 2003 Feb 20;103(5):652-6. doi: 10.1002/ijc.10893. Int J Cancer. 2003. PMID: 12494474

10

Tissue microarray analysis of signal transducers and activators of transcription 3 (Stat3) and phospho-Stat3 (Tyr705) in node-negative breast cancer shows nuclear localization is associated with a better prognosis.

Dolled-Filhart M, Camp RL, Kowalski DP, Smith BL, Rimm DL. Dolled-Filhart M, et al. Clin Cancer Res. 2003 Feb;9(2):594-600. Clin Cancer Res. 2003. PMID: 12576423

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

544 results

Search Page

Filters